Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction

Clinical Cardiology

Volumn 31, Issue 9, 2008, Pages 413-418

  Tan, Jing ^a   Hua, Qi ^a   Gao, Jing ^a   Zhen, Xing Fan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; Inflammation; Myocardial infarction

Indexed keywords

CD40 LIGAND; CREATINE KINASE; INTERLEUKIN 6; METALLOPROTEINASE; METALLOPROTEINASE 9; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; ST SEGMENT ELEVATION;

BIOLOGICAL MARKERS; CD40 LIGAND; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 53049095499     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20254     Document Type: Article

References (16)

1. Ross R: Atherosclerosis- an inflammatory disease. N Engl J Med 1999;340:115-126
2. Libby P: Inflammation in atherosclerosis. Nature 2002;420:868-874
3. Schroeder AP, Falk E: Pathophysiology and inflammatory aspects of plaque rupture. Cardiol Clin 1996;14:211-220
4. Fichtlscherer S, Heeschen C, Zeiher AM: Inflammatory markers and coronary artery disease. Curr Opin Pharmacol 2004;4:124-131
5. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined- a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969
6. Zairis MN, Adamopoulou EN, Manousakis SJ, Lyras AG, Bibis GP, et al.: The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiac mortality in patients with acute coronary syndromes. Atherosclerosis 2006;Doi: 10.1016/j.atherosclerosis.2006.08.008
7. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767-1772
8. Koukkunen H, Penttila K, Kemppainen A, Halinen M, Penttila I, et al.: C-reactive protein, fibrinogen, interleukin-6 and tumor necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 2001;33:37-47
9. Ohtsuka T, Hamada M, Inoue K, Ohshima K, Sujzuki J, et al.: Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction. Clin Cardiol 2004;27:417-420
10. Phipps RP: Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci U S A 2000;97:6930-6932
11. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P: Activation of monocyte/macrophage functions related to acute atheroma complicaion by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997;96:396-399
12. Shah PK, Falk F, Badimon JJ, Fernandez-Ortiz A, Mailhac A, et al.: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995;92:1565-1569
13. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, et al.: Soluble CD40L ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-1111
14. Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, et al.: Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 2003;108:1049-1052
15. Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, et al.: Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001;141:211-217
16. Manginas A, Bei F, Chaidaroglou A, Degiannis D, Koniavitou K, et al.: Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin 1. Clin Cardiol 2005;28:182-186